Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Zhejiang Medicine CoSHSE:600216 -8.88%79 OCF Yield % is 13.21 as of Aug. 22, 2026, which is 107% above its 10-year median of 6.38. GuruFocus rates SHSE:600216 with a GF Score™ of 79/100 and a GF Value™ of ¥13.92 (Fairly Valued). The stock has 6 warning signs investors should review. Among 1,004 Drug Manufacturers companies, Zhejiang Medicine Co ranks better than 86.35% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
The historical rank and industry rank for Zhejiang Medicine Co's OCF Yield % or its related term are showing as below:
SHSE:600216'
s OCF Yield % Range Over the Past 10 Years
Min: 1.63 Med: 6.38 Max: 15.56
Current: 13.21
During the past 13 years, the highest OCF Yield % of Zhejiang Medicine Co was 15.56%. The lowest was 1.63%. And the median was 6.38%.
SHSE:600216's OCF Yield % is ranked better than 86.35% of 1004
companies
in the Drug Manufacturers industry
Industry Median: 3.395
vs SHSE:600216: 13.21
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Zhejiang Medicine Co OCF Yield % Related Terms
Zhejiang Medicine Co OCF Yield % Historical Data
* Premium members only.
The historical data trend for Zhejiang Medicine Co's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Zhejiang Medicine Co's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zhejiang Medicine Co OCF Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Zhejiang Medicine Co's OCF Yield % distribution charts can be found below:
* The bar in red indicates where Zhejiang Medicine Co's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zhejiang Medicine Co (SHSE:600216) has a OCF Yield % of 13.21 as of Aug. 22, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Zhejiang Medicine Co and its competitors. This is 107% above median its historical median of 6.38. Over the past decade, Zhejiang Medicine Co's OCF Yield % has ranged from 1.63 to 15.56. According to the industry distribution chart, Zhejiang Medicine Co ranks #137 out of 1004 companies in the Drug Manufacturers industry, placing it in the top 13.6%.
Is Zhejiang Medicine Co's OCF Yield % too high?
Zhejiang Medicine Co's current OCF Yield % of 13.21 is 107% above median its 10-year median of 6.38. Over the past 10 years, this metric has ranged from a low of 1.63 to a high of 15.56. The Drug Manufacturers industry median OCF Yield % is 3.40. Zhejiang Medicine Co's value of 13.21 is 289.1% above this industry median. Based on the distribution chart, Zhejiang Medicine Co ranks #137 out of 1004 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Zhejiang Medicine Co has a GF Score™ of 79/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Zhejiang Medicine Co's OCF Yield % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Zhejiang Medicine Co ranks #137 out of 1004 companies for OCF Yield %. This places Zhejiang Medicine Co in the top 14% of its industry — outperforming the majority of peers. The industry median OCF Yield % is 3.40. Zhejiang Medicine Co's value of 13.21 is 289.1% above this benchmark. Historically, Zhejiang Medicine Co's own OCF Yield % has ranged from 1.63 to 15.56 over the past decade. While the company's 10-year median is 6.38 vs. the industry median of 3.40, Zhejiang Medicine Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Drug Manufacturers company?
The median OCF Yield % among Drug Manufacturers companies is 3.40, based on 1,004 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Zhejiang Medicine Co's current OCF Yield % of 13.21 is 289.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Zhejiang Medicine Co and its competitors. For the Drug Manufacturers industry, the median OCF Yield % is 3.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zhejiang Medicine Co's current OCF Yield % is 13.21, which is 107% above median its own 10-year median of 6.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhejiang Medicine Co stock overvalued right now?
Based on GuruFocus' analysis, Zhejiang Medicine Co (SHSE:600216) is currently considered Fairly Valued. The stock's GF Value™ is ¥13.92, compared to a current price of ¥13.23 — trading 5% below its estimated fair value. The current OCF Yield % is 13.21, which is 107% above median its 10-year median of 6.38 and 289.1% above the Drug Manufacturers industry median of 3.40. Zhejiang Medicine Co's overall GF Score™ is 79/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Zhejiang Medicine Co (SHSE:600216), the current OCF Yield % is 13.21 as of Aug. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Zhejiang Medicine Co (SHSE:600216) Overvalued in 2026?
Based on GuruFocus' analysis, Zhejiang Medicine Co stock appears to be undervalued.
The current stock price of ¥13.23 is trading 5% below its estimated GF Value™ of ¥13.92.
GuruFocus considers Zhejiang Medicine Co to be Fairly Valued.
Key valuation signals for SHSE:600216:
OCF Yield %: 13.21 (107% above median its 10-year median of 6.38)
GF Value™: ¥13.92 vs. price of ¥13.23 (5% below fair value)
Industry Position: 289.1% above the Drug Manufacturers median (#137 of 1004)
No single metric tells the full story. See the SHSE:600216 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Zhejiang Medicine Co Ltd is a china-based pharmaceutical company. The company manufactures fat-soluble vitamins, vitamins, quinolones, and antibiotic-resistant antibiotics, vitamin E, natural vitamin E, beta-carotene, cantharidin, vancomycin hydrochloride, and teicoplanin.
79GF Score
Get the complete analysis for SHSE:600216
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600216 has been successfully added to your 
